Prevalence of Hemoglobinopathies in Premarital Screening in the Province of Nigde, Turkey

References

• Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med. 2012;2(9):a011692.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Regional Office for South-East Asia. 2021. Regional desk review of haemoglobinopathies with an emphasis on thalassaemia and accessibility and availability of safe blood and blood products as per these patients’ requirement in South-East Asia under universal health coverage. World Health Organization. Regional Office for South-East Asia. Available from: https://apps.who.int/iris/handle/10665/344889
   Google Scholar
• Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
   PubMed Web of Science ®Google Scholar
• Angastiniotis M, Lobitz S. Thalassemias: an overview. Int J Neonatal Screen. 2019;5(1):16.
   PubMed Web of Science ®Google Scholar
• Forget BG, Bunn HF. Classification of the disorders of hemoglobin. Cold Spring Harb Perspect Med. 2013;3(2):a011684.
   PubMed Web of Science ®Google Scholar
• Goonasekera HW, Paththinige CS, Dissanayake VHW. Population screening for hemoglobinopathies. Annu Rev Genomics Hum Genet. 2018;19:355–380.
   PubMed Web of Science ®Google Scholar
• Angastiniotis M, Vives Corrons JL, Soteriades ES, et al. The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders. ScientificWorldJournal. 2013;2013(Special issue):727905.
   PubMed Web of Science ®Google Scholar
• Republic of Turkey Ministry of Health, General Directorate of Public Health, Department of Child and Adolescent Health. Hemoglobinopathy control program. [cited 2022 Dec 15] Available from: https://hsgm.saglik.gov.tr/tr/cocukergen-tp-liste/hemoglobinopati-kontrol-program.ı.html
   Google Scholar
• Canatan D. Türkiye’de hemoglobinopatilerin epidemiyolojisi. Hematology. 2014;4-1:11–21.
   Google Scholar
• Kattamis A, Forni GL, Aydinok Y, et al. Changing patterns in the epidemiology of β-thalassemia. Eur J Haematol. 2020;105(6):692–703.
   PubMed Web of Science ®Google Scholar
• Karakukcu C, Kocer D, Altuner Torun Y, et al. Premarital hemoglobinopathy screening in Kayseri: a city in Middle Anatolia region of Turkey. J Pediatr Hematol Oncol. 2012;34(2):e49–e52.
   PubMed Web of Science ®Google Scholar
• Canatan D. Haemoglobinopathy prevention program in Turkey. Thalass. Rep. 2011;1(12):e4.
   Google Scholar
• Canatan D, Vives Corrons JL, Piacentini G, et al. Immigration and screening programs for hemoglobinopathies in Italy, Spain and Turkey. Acta Biomed. 2021;92(4):e2021410.
   PubMedGoogle Scholar
• Tosun F, Bilgin A, Kızılok A, et al. Five-year evaluation of premarital screening program for hemoglobinopathies in the province of Mersin, Turkey. Turk J Haematol. 2006;523(2):84–89.
   PubMedGoogle Scholar
• Guler E, Caliskan U, Ucar Albayrak C, et al. Prevalence of β-thalassemia and sickle cell anemia trait in premarital screening in Konya urban area, Turkey. J Pediatr Hematol Oncol. 2007;29(11):783–785.
   PubMed Web of Science ®Google Scholar
• Uysal A, Genc A, Taşyürek N, et al. Prevalence of β-thalassemia trait and abnormal hemoglobin in premarital screening in the province of Izmir, Turkey. Pediatr Hematol Oncol. 2013;30(1):46–50.
   PubMed Web of Science ®Google Scholar
• Ulutaş KT, Şahpaz F, Sarıcı IŞ, et al. A screening study on premarital hemoglobinopathy: Is Kadirli a risk-bearing region for β-thalassemia in Turkey? Turk J Biochem. 2014;39(3):357–361.
   Web of Science ®Google Scholar
• Republic of Turkey Ministry of Health, General Directorate of Public Health. Hemoglobinopati Tanı Rehberi. 2016 [cited 2022 Sep 13] Available from: https://hsgm.saglik.gov.tr/tr/tghsldb-rehberler/hemoglobinopati-tan%C4%B1-rehberi.html
   Google Scholar
• Tadmouri GO, Başak AN. β-thalassemia in Turkey: a review of the clinical, epidemiological, molecular, and evolutionary aspects. Hemoglobin. 2001;25(2):227–239.
   PubMed Web of Science ®Google Scholar
• Galanello R, Origa R. β-thalassemia. Orphanet J Rare Dis. 2010;5:11.
   PubMed Web of Science ®Google Scholar
• Needs T, Gonzalez-Mosquera LF, Lynch DT. β thalassemia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
   Google Scholar
• Origa R. β-Thalassemia. Genet Med. 2017;19(6):609–619.
   PubMed Web of Science ®Google Scholar
• Canatan D, Kose MR, Ustundag M, et al. Hemoglobinopathy control program in Turkey. Community Genet. 2006;9(2):124–126.
   PubMedGoogle Scholar
• Kanavakis E, Wainscoat JS, Wood WG, et al. The interaction of α thalassaemia with heterozygous β thalassaemia. Br J Haematol. 1982;52(3):465–473.
   PubMed Web of Science ®Google Scholar
• Melis MA, Pirastu M, Galanello R, et al. Phenotypic effect of heterozygous α and β 0-thalassemia interaction. Blood. 1983;62(1):226–229.
   PubMed Web of Science ®Google Scholar
• Altay Ç. Abnormal hemoglobins in Turkey. Turk J Haematol. 2002;19(1):63–74.
   PubMedGoogle Scholar
• De Sanctis V, Kattamis C, Canatan D, et al. β-Thalassemia distribution in the old world: an ancient disease seen from a historical standpoint. Mediterr J Hematol Infect Dis. 2017;9(1):e2017018.
   PubMed Web of Science ®Google Scholar
• Guvenc B, Canataroglu A, Unsal C, et al. β-Thalassemia mutations and hemoglobinopathies in Adana, Turkey: results from a single center study. Arch Med Sci. 2012;8(3):411–414.
   PubMed Web of Science ®Google Scholar
• Canatan D, Arcasoy A, Bor S, et al. Screening of abnormal hemoglobins and high HbA2 β-thalassemia in Elbistan area. Doga Tr J Med Sci. 1990;14:555–561.
   Google Scholar
• Liapis K. Haemoglobin electrophoresis and HPLC. Haema. 2021;12(1):39–41.
   Google Scholar
• Weatherall DJ. Hemoglobin E β-thalassemia: an increasingly common disease with some diagnostic pitfalls. J Pediatr. 1998;132(5):765–767.
   PubMed Web of Science ®Google Scholar
• Tatu T. Laboratory diagnosis of β-thalassemia and HbE. In: Zakaria M, Hassan T, editors. β thalassemia. London (UK): Intechopen Ltd.; 2020. p. 1–39.
   Google Scholar
• Karna B, Jha SK, Al Zaabi E. Hemoglobin C disease. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
   Google Scholar
• Verma S, Bhargava M, Mittal S, et al. Homozygous delta-β thalassemia in a child: a rare cause of elevated fetal hemoglobin. Iran J Ped Hematol Oncol. 2013;3(1):222–227.
   PubMedGoogle Scholar
• Weatherall D. The thalassemias. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligshon U, editors. Williams hematology. 6th ed. New York (NY): McGraw-Hill; 2001. p. 547–605.
   Google Scholar
• Bain BJ, Wild BJ, Stephens AD, et al. Variant haemoglobins: a guide to identification. Oxford: Wiley-Blackwell; 2010.
   Google Scholar
• Dass J, Gupta A, Mittal S, et al. Comparison of the characteristics of two hemoglobin variants, Hb D-Iran and Hb E, eluting in the Hb A2 window. Blood Res. 2017; 52(2):130–134.
   PubMed Web of Science ®Google Scholar
• Joutovsky A, Hadzi-Nesic J, Nardi MA. HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem. 2004;50(10):1736–1747.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP. Clinical manifestations of α-thalassemia. Cold Spring Harb Perspect Med. 2013;3(5):a011742.
   PubMed Web of Science ®Google Scholar
• De Benoist B, McLean E, Egli I, et al. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. Geneva: World Health Organization; 2008.
   Google Scholar
• Angastiniotis M, Cannon L, Antoniou E, et al. Hemoglobin disorders in Europe: a systematic effort of identifying and addressing unmet needs and challenges by the Thalassemia International Federation. Thalass. Rep. 2021; 11(1):9803.
   Web of Science ®Google Scholar
• Aramayo-Singelmann C, Halimeh S, Proske P, et al. Screening and diagnosis of hemoglobinopathies in Germany: current state and future perspectives. Sci Rep. 2022;12(1):9762.
   PubMed Web of Science ®Google Scholar
• United Nations High Commissioner for Refugees (UNHCR). [cited 2022 Dec 10] Available from: https://www.unhcr.org/refugee-statistics/
   Google Scholar
• United Nations High Commissioner for Refugees (UNHCR). [cited 2022 Dec 15] Available from: https://www.unhcr.org/figures-at-a-glance.html
   Google Scholar
• T.R. Presidency of Migration Management of the Ministry of Interior. [cited 2022 Dec 10] Available from: https://en.goc.gov.tr/temporary-protection27
   Google Scholar